SecBot SecBot
S-3 ·Filed Nov 10, 2026

ATRA

Atara Biotherapeutics, Inc.
BEARISH
Impact 5/10
Processed1h 56m ago SEC0001104659-26-125314
Shelf registration (potential dilution)

Price Chart

Loading chart...

Investment Themes

Documents Analyzed

This report is based on 7 SEC documents filed with EDGAR.

DocumentAccession Number
S-3 Filing (Primary)0001104659-26-125314
Document: tm2629234d1_ex-filingfees.htm0001104659-26-125314
Document: tm2629234d2_ex5-1.htm0001104659-26-125314
Document: tm2629234d2_ex23-1.htm0001104659-26-125314
Document: 0001104659-26-125314-index-headers.html0001104659-26-125314
Document: 0001104659-26-125314-index.html0001104659-26-125314
Document: 0001104659-26-125314.txt0001104659-26-125314

US Market Status

Market Closed · Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 10, 2026

Fresh ATRA Intelligence

Analysis is for subscribers only.

Subscribe for Full Access